Your browser does not support java script. Skip navigation
Loading, please wait  Loading, please wait...

Pre-Psy Session: Recognizing Tardive Dyskinesia & Using the AIMS to Assess for Tardive Dyskinesia


Recognizing Tardive Dyskinesia & Using the AIMS to Assess for Tardive Dyskinesia - Included in Conference Registration
 

This special program provides participants with updates on Tardive Dyskinesia, information on diagnosis, and training on the use of the Abnormal Involuntary Movement Scale (AIMS).  The program will include a brief review of the different forms of EPS or Drug Induced Movement Disorders, clarifying the differentiation between. Pseudoparkinsonism, Akathisia, Tardive Dyskinesia, and Dystonia.  Next, participants will practice using the Abnormal Involuntary Movement Scale (AIMS), simulated with small groups including direct instructor feedback.

 
Presented By:
Steve Stoner, PharmD, BCPP
Chair and Clinical Professor
Division of Pharmacy Practice and Administration
University of Missouri Kansas City School of Pharmacy
 
With
 
Stephen R. Saklad, Pharm.D., BCPP
Clinical Associate Professor
The University of Texas at Austin College of Pharmacy
 

Registration fees are included with full registration to the 31st Psychiatric Pharmacotherapy Update Conference
Use Coupon Code: Psych19DL
Non Conference Registrants may resister for this session alone at a $50 registration fee.

 
 

Date: Oct 16, 2019 06:00 PM - 08:30 PM

Fee

$80.00

CE Hours

2.00

CE Units

0.200

Registration closes on Oct 16, 2019 07:00 PM

Activity Type

  • Application

Target Audience(s)

  • Pharmacists
  • Physicians
  • Psychiatrists
  • Psychologists
  • Social Workers

 

 

Registration Closed  

Objectives

  • Differentiate between tardive dyskinesia and other drug induced movement disorders.
  • Describe the Abnormal Involuntary Movement Scale (AIMS) and how it is utilized to assess the frequency and severity of movements associated with TD
  • Describe best practices in the administration and interpretations of the AIMS
  • Review simulated scenarios of patients with TD and practice assessment and interpretation of findings.

Speaker(s)/Author(s)

Steven Stoner, PharmD BCPP, PharmD, BCPP
Chair and Clinical Professor, Univ of Missouri Kansas City School of Pharmacy

Activity Number

0067-0000-19-115-L01-P
Date: 10/16/19
Time: 06:00 PM - 08:30 PM

CE Hours

2.00
Registration Closed